Recent Progress in the Development of Opaganib for the Treatment of Covid-19

The Covid-19 pandemic driven by the SARS-CoV-2 virus continues to exert extensive humanitarian and economic stress across the world. Although antivirals active against mild disease have been identified recently, new drugs to treat moderate and severe Covid-19 patients are needed. Sphingolipids regul...

Descripción completa

Detalles Bibliográficos
Autores principales: Smith, Charles D, Maines, Lynn W, Keller, Staci N, Katz Ben-Yair, Vered, Fathi, Reza, Plasse, Terry F, Levitt, Mark L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9288228/
https://www.ncbi.nlm.nih.gov/pubmed/35855741
http://dx.doi.org/10.2147/DDDT.S367612

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9288228/
https://www.ncbi.nlm.nih.gov/pubmed/35855741
http://dx.doi.org/10.2147/DDDT.S367612

Ejemplares similares